therapeutical options
In case of Atrial Fibrillation, there are various options that can help to solve or manage the problem.

First of all, your doctor will choose one among two therapeutical strategies; rhythm control or rate control.
These treatment strategies should be supported by an anti-thrombotic therapy.
A thrombus is a blood clot that can potentially cause a stroke
The treatment strategies described above should be supported by an anti-thrombotic therapy.

A thrombus is a blood clot that can potentially cause a stroke. To prevent its formation, patients are treated with anti-platelet or oral anticoagulant drugs.
ANTI-PLATELET DRUGS
An anti-platelet drug commonly used for patients with atrial fibrillation is aspirine, reducing the risk of stroke of nearly 20%.

 

ANTICOAGULANT DRUGS
Oral anticoagulant drugs like warfarin and dabigatran are more effective, reducing the risk of stroke of 60%, but increasing the risk of haemorrhages.

 

Your doctor will suggest the therapy that best suits you, considering the type of atrial fibrillation, your symptoms and the blood test results.
Generally speaking, aspirine is given to people who show a low thromboembolic risk, whereas oral anticoagulant drugs are more suitable for those with average or high thromboembolic risk.

Low thromboembolic risk (CHA2DS2VASc 0) = aspirin
Average / high thromboembolic risk (CHA2DS2VASc ≥1) = warfarin, dabigatran

In patients with Atrial Fibrillation and high thromboembolic risk, it is possible to occlude the atrial appendage percutaneously, either surgically or by using a device.


 
More about the
STOP FA
campaign!

stopfa

Watch the Educational Video
video
Join our newsletter

Insert your email and